EthanDanielHausmanMD

Other MD/DO • Silver Spring, MD

Medical Officer, US Food and Drug Administration

Join to view full profile

Dr. Hausman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hausman's full profile

Already have an account?

Office
Avenue
Silver Spring, MD 20993
Is this information wrong?

Education & Training

MedStar Health/Georgetown University HospitalResidency, Pediatrics, 1996 - 1999
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Blood Banking/Transfusion Medicine, 1995 - 1996
Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Pathology-Anatomic and Clinical, 1991 - 1995
Albany Medical CollegeClass of 1991

Certifications & Licensure

VA State Medical License 1999 - 2026
CA State Medical License 1997 - 2025
MA State Medical License 1994 - 2025
American Board of Pathology Clinical Pathology
American Board of Pediatrics Pediatrics

Publications & Presentations

PubMed

5 citations
Considerations and Challenges in the Remdesivir COVID-19 Pediatric Development Program.
Kirk Chan-Tack, Mario Sampson, Justin Earp, Vikram Arya, Lynne Yao
Journal of Clinical Pharmacology. 2023-02-01
57 citations
Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium.
Jane P. F. Bai, Ethan Hausman, Robert Lionberger, Xinyuan Zhang
Molecular Pharmaceutics. 2012-11-02
5 citations
The red cell chemokine receptor is distinct from the Fy6 epitope
E Hausman, Walter H. Dzik, D Blanchard
Transfusion. 1996-05-01

Books/Book Chapters

Pediatric Drug Development Concepts and Applications
Chapter: Clinical Laboratory Testing in Clinical Trials For Pediatric Subjects
Page 517 - 529Mulberg A, Hausman EEditors: Mulberg A, Murphy D, Dunne J, Mathis L..Wiley & Sons, HobokenEdition 2nd,2013

Abstracts/Posters

FDA evaluation of hepatotoxicity related to tyrosine kinase inhibitors
Chang J, Rand M, Blumenthal GM, Cortazar P, Kulick C, Hausman E, et al., Journal of Clinical Oncology 2011, 29:15_suppl, 3106-3106, 2011

Press Mentions

Teething Gel Causes Toddler to Stop BreathingMarch 13th, 2018
Don't Use Prescription Drugs to Relieve Babies of Teething Pain: FDA WarnsJune 27th, 2014
Numbing Medications Can Harm Teething Babies, FDA WarnsJune 26th, 2014
Join now to see all